Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome.
暂无分享,去创建一个
Kiyotaka Fukamachi | Soren Schenk | Jose L Navia | Eugene H Blackstone | Jingyuan Feng | N. Smedira | E. Blackstone | P. McCarthy | R. Starling | S. Schenk | Jingyuan Feng | J. Navia | Lingmei Zhou | K. Hoercher | K. Fukamachi | Randall C Starling | Lingmei Zhou | Patrick M McCarthy | Nicholas G Smedira | Katherine J Hoercher
[1] M. Oz,et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. , 2002, The Annals of thoracic surgery.
[2] A. Pavie,et al. Bridge to transplantation with the Jarvik-7 (CardioWest) total artificial heart: a single-center 15-year experience. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[3] Kiyotaka Fukamachi,et al. Predictors of Severe Right Ventricular Failure After Implantable Left Ventricular Assist Device Insertion: Analysis of 245 Patients , 2002, Circulation.
[4] Malcolm E. Turner,et al. The Decomposition of Time-Varying Hazard into Phases, Each Incorporating a Separate Stream of Concomitant Information , 1986 .
[5] Leo Breiman,et al. Bagging Predictors , 1996, Machine Learning.
[6] S. Bolling,et al. Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization. , 1999, Circulation.
[7] L. Wiklund,et al. Risk factor analysis of Swedish Left Ventricular Assist Device (LVAD) patients. , 2003, The Annals of thoracic surgery.
[8] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[9] N G Smedira,et al. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. , 1999, The Annals of thoracic surgery.
[10] L. Gray,et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. , 1997, The Journal of thoracic and cardiovascular surgery.
[11] M. Oz,et al. Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? , 1997, Circulation.
[12] B. Lytle,et al. Competing risks after coronary bypass surgery: the influence of death on reintervention. , 2000, The Journal of thoracic and cardiovascular surgery.
[13] H. A. David,et al. The Theory of Competing Risks. , 1979 .
[14] O H Frazier,et al. Surgery for Acquired Cardiovascular Disease Initial experience with the AbioCor Implantable Replacement Heart System , 2004 .
[15] R. Cody,et al. Short-term use of intravenous milrinone for heart failure. , 1995, The American journal of cardiology.
[16] N. Smedira,et al. Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation? , 2002, The Annals of thoracic surgery.
[17] James W Long,et al. Surgical management of patients in the REMATCH trial. , 2003, The Annals of thoracic surgery.
[18] M. Oz,et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. , 2001, The Journal of thoracic and cardiovascular surgery.
[19] H. A. David. The theory of competing risks , 1980 .
[20] A. Pavie,et al. Mechanical Circulatory Support for Advanced Heart Failure , 2001 .
[21] E. Blackstone,et al. Analysis of morbid events and risk factors for death after cardiac transplantation. , 1988, Journal of the American College of Cardiology.